Jump to main content
Jump to site search

Issue 3, 2015
Previous Article Next Article

Mesoporous silica–chondroitin sulphate hybrid nanoparticles for targeted and bio-responsive drug delivery

Author affiliations

Abstract

This work proposes the fabrication of a novel targeted drug delivery system based on mesoporous silica-biopolymer hybrids that can release drugs in response to biological stimuli present in cancer cells. The proposed system utilizes mesoporous silica nanoparticles as a carrier to host the drug molecules. A bio-polymer cap is attached onto these particles which serves the multiple functions of drug retention, targeting and bio-responsive drug release. The biopolymer chondroitin sulphate used here is a glycosaminoglycan that can specifically bind to receptors over-expressed in cancer cells. This molecule also possesses the property of disintegrating upon exposure to enzymes over-expressed in cancer cells. When these particles interact with cancer cells, the chondroitin sulphate present on the surface recognizes and attaches onto the CD44 receptors facilitating the uptake of these particles. The phagocytised particles are then exposed to the degradative enzymes, such as hyaluronidase present inside the cancer cells, which degrade the cap resulting in drug release. By utilizing a cervical cancer cell line we have demonstrated the targetability and intracellular delivery of hydrophobic drugs encapsulated in these particles. It was observed that the system was capable of enhancing the anticancer activity of the hydrophobic drug curcumin. Overall, we believe that this system might prove to be a valuable candidate for targeted and bioresponsive drug delivery.

Graphical abstract: Mesoporous silica–chondroitin sulphate hybrid nanoparticles for targeted and bio-responsive drug delivery

Back to tab navigation

Supplementary files

Publication details

The article was received on 25 Aug 2014, accepted on 12 Dec 2014 and first published on 15 Dec 2014


Article type: Paper
DOI: 10.1039/C4NJ01430H
Author version
available:
Download author version (PDF)
Citation: New J. Chem., 2015,39, 1754-1760
  •   Request permissions

    Mesoporous silica–chondroitin sulphate hybrid nanoparticles for targeted and bio-responsive drug delivery

    K. Radhakrishnan, J. Tripathy, A. Datey, D. Chakravortty and A. M. Raichur, New J. Chem., 2015, 39, 1754
    DOI: 10.1039/C4NJ01430H

Search articles by author

Spotlight

Advertisements